These 9 biotech stocks have doubled this year and are set to double again, analysts say
The bio tech stocks have on average risen by 188% this year and have a median upside potential of 150%.
Read MoreThe bio tech stocks have on average risen by 188% this year and have a median upside potential of 150%.
Read MoreThese are the stocks posting the largest moves in midday trading. Source link
Read More